![NGX6 expression improves the sensitivity of tamoxifen-resistant MCF-7 cells through modulation of the Smad signaling pathway NGX6 expression improves the sensitivity of tamoxifen-resistant MCF-7 cells through modulation of the Smad signaling pathway](https://www.spandidos-publications.com/article_images/ijo/42/6/IJO-42-06-2060-g13.jpg)
NGX6 expression improves the sensitivity of tamoxifen-resistant MCF-7 cells through modulation of the Smad signaling pathway
![A study on platinum(iv) species containing an estrogen receptor modulator to reverse tamoxifen resistance of breast cancer†,Metallomics - X-MOL A study on platinum(iv) species containing an estrogen receptor modulator to reverse tamoxifen resistance of breast cancer†,Metallomics - X-MOL](https://xpic.x-mol.com/20180222%2F10.1039_C7MT00289K.jpg)
A study on platinum(iv) species containing an estrogen receptor modulator to reverse tamoxifen resistance of breast cancer†,Metallomics - X-MOL
![Tamoxifen and its active metabolites inhibit dopamine transporter function independently of the estrogen receptors - Mikelman - 2017 - Journal of Neurochemistry - Wiley Online Library Tamoxifen and its active metabolites inhibit dopamine transporter function independently of the estrogen receptors - Mikelman - 2017 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/99231605-2b96-4c5a-be39-0f659dcf0056/jnc13955-fig-0004-m.jpg)
Tamoxifen and its active metabolites inhibit dopamine transporter function independently of the estrogen receptors - Mikelman - 2017 - Journal of Neurochemistry - Wiley Online Library
![Genome-wide analysis of therapeutic response uncovers molecular pathways governing tamoxifen resistance in ER+ breast cancer - EBioMedicine Genome-wide analysis of therapeutic response uncovers molecular pathways governing tamoxifen resistance in ER+ breast cancer - EBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/2d036ff1-39c3-454a-bd50-d673fd8f1b6c/gr1.jpg)
Genome-wide analysis of therapeutic response uncovers molecular pathways governing tamoxifen resistance in ER+ breast cancer - EBioMedicine
![Figure 2 from ICI 182,780 (Fulvestrant™) – the first oestrogen receptor down-regulator – current clinical data | Semantic Scholar Figure 2 from ICI 182,780 (Fulvestrant™) – the first oestrogen receptor down-regulator – current clinical data | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fa0103655ba106ae8600571c39afd3b44f30e8d6/2-Figure2-1.png)